Reports

Interim reports

Interim report Q3 2020 statement
Half-year Report 2020
Interim report Q1 2020 statement
Interim report Q3 2019 statement
Half-year Report 2019
Interim report Q1 2019 statement
Interim report Q3 2018 statement
Half-year Report 2018

Annual reports

Annual Report 2019
Annual Report 2018
Annual Report 2017

Year-end reports

Year-end Report 2020
Year-end Report 2019
Year-end Report 2018

Rights issue 2019

Prospectus for Scandion Oncology

IPO 2018

Memorandum for Scandion Oncology

 

Scandion Oncology Investor Relations

Bo Rode Hansen, CEO
E: ir@scandiononcology.com
T: +45 38 10 20 17

Investor information
Nasdaq Stockholm AB
Nasdaq First North Growth Market
105 78 Stockholm
Visiting address: Tullvaktsvägen 15
Tel: +46 8 405 60 00
www.nasdaqomxnordic.com
Certified Advisor
Västra Hamnen Corporate Finance AB
Jungmansgatan 12
211 11 Malmö
Phone: +46 40-200 250
Email: ca@vhcorp.se
Website: www.vhcorp.se
Co-funded by the Horizon 2020 programme of the European Union
Co-funded by the COSME programme of the European Union
Privacy and Cookie Policy